Rockwell Medical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RMTI research report →
About the company
Rockwell Medical, Inc. , together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease. The company provides a range of therapies and products aimed at addressing iron deficiency and supporting hemodialysis procedures, serving markets both within the United States and internationally.
- CEO
- Mark Strobeck
- IPO
- 1998
- Employees
- 244
- HQ
- Wixom, MI, US
Price Chart
- Market Cap
- $21.87M
- P/E
- -3.73
- P/S
- 0.32
- P/B
- 0.61
- EV/EBITDA
- -10.27
- Div Yield
- 0.00%
- Gross Margin
- 17.07%
- Op Margin
- -7.11%
- Net Margin
- -7.98%
- ROE
- -15.41%
- ROIC
- -9.57%
- Revenue
- $69.26M · -31.76%
- Net Income
- $-5,314,000 · -1007.08%
- EPS
- $-1.50 · -495.24%
- Op Income
- $-4,691,000
- FCF YoY
- -137.64%
- 52W High
- $21.00
- 52W Low
- $4.88
- 50D MA
- $7.43
- 200D MA
- $9.51
- Beta
- 1.61
- Avg Volume
- 31.56K
Get TickerSpark's AI analysis on RMTI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 20, 25 | Neri Jesse | other | 97,500 |
| May 20, 25 | TIMMINS MEGAN C. | other | 97,500 |
| May 20, 25 | Chole Timothy | other | 85,000 |
| May 20, 25 | Strobeck Mark | other | 352,000 |
| Mar 14, 26 | Hunter Heather | other | 2,444 |
| Mar 14, 26 | TIMMINS MEGAN C. | other | 3,667 |
| Mar 14, 26 | Neri Jesse | other | 2,444 |
| Mar 14, 26 | Chole Timothy | other | 2,444 |
| Mar 14, 26 | Strobeck Mark | other | 7,333 |
| Jan 2, 26 | Hunter Heather | sell | 2,868 |
Our RMTI coverage
Recent articles, reports, and earnings notes.
No research on RMTI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RMTI report →Similar companies
Peers in the same neighborhood.